Functional studies indicated that Myo1b acts as a pivotal autophagy regulator by modulating the autophagosome-lysosome fusion, which could inhibit the autophagic degradation of HIF-1α, thus enhancing VEGF secretion and then promoting tumor angiogenesis in CRC. Here, MYO1B is linked to colorectal carcinoma.